kaiyun(Öйú)¹Ù·½ÍøÕ¾-¿ªÔÆÌåÓý¹Ù·½Èë¿Ú

Sitagliptin (phosphate)

Sitagliptin (phosphate) £¨¶©»õÒÔCAS±àÂë»òÓ¢ÎÄÃû³ÆÎª×¼£©

DPP-4ÒÖÖÆ¼Á
MedBioÌṩµÄËùÓвúÆ·½öÓÃÓÚ¿ÆÑеȷÇÒ½ÁÆÓÃ;£¬·ÇÒ©Æ·²»¿ÉʳÓ㬲»¿ÉÓÃÓÚÈËÌå»ò¶¯ÎïµÄÁÙ´²Õï¶ÏºÍÖÎÁÆ,ÎÒÃDz»Îª¸öÈËÌṩ²úÆ·¼°·þÎñ¡£ÈçÄúÐèÒª²úÆ·COAµÈ×ÊÁÏ£¬¿ÉÖÁÏ·½¡°ÖÊÁ¿¿ØÖÆ¡±ÖÐÏÂÔØ
±àºÅ£ºMED18553
·Ö×Óʽ£ºC16H18F6N5O5P
CASºÅ£º654671-78-0
·Ö×ÓÁ¿£º505.31
ÉêÇëÊÔÓÃ
»õºÅ Æ·ÅÆ ¹æ¸ñ ´¿¶È/º¬Á¿ ±ê×¼¼Û ÓÅ»Ý¼Û ¿â´æ»õÆÚ ÊýÁ¿ ¹ºÂò
MED18553-10mM (in 1mL DMSO) MedBio 10mM (in 1mL DMSO) ¡Ý98% ?489.00 µÇ¼ºó¿É¼û
MED18553-100mg MedBio 100mg ¡Ý98% ?626.00 µÇ¼ºó¿É¼û
MED18553-250mg MedBio 250mg ¡Ý98% ?1315.00 µÇ¼ºó¿É¼û
MED18553-1g MedBio 1g ¡Ý98% ?3759.00 µÇ¼ºó¿É¼û
MED18553-50mg MedBio 50mg ¡Ý98% ?366.00 µÇ¼ºó¿É¼û
ÖÐÎÄÃû³Æ£º Á×ËáÎ÷ËûÁÐÍ¡
ÖÐÎıðÃû£º Á×ËáÎ÷ËûÁÐÍ¡;4-Ñõ´ú-4-(3-Èý·ú¼×»ù-5,6-¶þÇâ(1,2,4)Èýßò²¢[4,3-a]ßÁàº-7(8H)-»ù)-1-(2,4,5-Èý·ú±½»ù)¶¡-2-°·Á×ËáÑÎ;Á×ËáÎ÷ËûÁÐÍ¡ Á×ËáÎ÷ËûÁÐ͡һˮ»¯Îï;Î÷ËûÁÐÍ¡Á×ËáÑÎ;ÎÞË®Á×ËáÎ÷ËûÁÐÍ¡;Á×ËáÎ÷¸ñÁÐ͡һˮºÏÎï;Á×ËáÎ÷ËûÁÐÍ¡£¨ÑΣ©;Á×ËáÎ÷ËûÁÐÍ¡ÎÞË®Îï;Á×ËáÎ÷ËûÁÐ͡һˮºÏÎï;Î÷¸ñÁÐÍ¡;һˮ»¯Îï
Ó¢ÎÄÃû³Æ£º Sitagliptin (phosphate)
Ó¢ÎıðÃû£º Sitagliptin phosphate;4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate;7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-¦Á]pyrazine-phosphate;Sitagliptin (phosphate);Sitagliptin Phosphat;MK0431 phosphate;MK-0431 phosphate;Sitagliptin;(3R)-3-aMino-1-[3-(trifluoroMethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
CASºÅ£º 654671-78-0
·Ö×Óʽ£º C16H18F6N5O5P
·Ö×ÓÁ¿£º 505.31
Íâ¹Û£º A crystalline solid
´¢´æÌõ¼þ -20¡ãC

DPP-4ÒÖÖÆ¼Á£¬Sitagliptin(MK 0431)Á×ËáÑÎÊÇDPP4ÒÖÖÆ¼Á£¬¶ÔCaco-2ϸ°ûÌáÈ¡ÎïµÄIC50Ϊ19 nM¡£

ËÑË÷Öʼ챨¸æ(COA)
Ïà¹Ø²úÆ·
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿